Gelonghui October 18th | *Special Treat Jingfeng (000908.SZ) announced that the company and its holding subsidiaries intend to engage in entrusted research and development transactions with the subsidiary of cspc pharma group limited (referred to as "cspc pharma group"), Chiqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (referred to as "Chiqi Pharmaceuticals"), according to the needs of development. The total amount of the related transactions is expected to be no more than 10 million yuan, and the above limit is valid for a period of 3 years from the date of approval by the board of directors.